logo
logo

Ad Astra Diagnostics awarded $5 million federal contract for next gen CBC and sepsis diagnostic system

Ad Astra Diagnostics awarded $5 million federal contract for next gen CBC and sepsis diagnostic system

10/24/24, 11:48 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgnorth carolina
Money
$5 million
Industry
biotechnology
health care
Type
contract
Ad Astra Diagnostics has been awarded a $5 million federal contract with potential to award up to $12.6 million for the development of an improved diagnostic system designed to deliver faster complete blood count (CBC) test results and the earlier detection of severe infection, including sepsis. The QScout CBC system aims to be the most comprehensive patient-side CBC for earlier identification and triage of severe infection.

Company Info

Company
Ad Astra Diagnostics
Location
north carolina, united states
Additional Info
Ad Astra Diagnostics is a developer of rapid diagnostic and data systems, aiming to improve patient-side CBC and the early detection of severe infections, including sepsis.